Intestinal carcinogenesis involves the successive accumulation of multiple genetic defects until cellular transformation to an invasive phenotype occurs. This process is modulated by many epigenetic factors. Unconjugated bile acids are tumor promoters whose presence in intestinal tissues is regulated by dietary factors. We studied the role of the unconjugated bile acid, chenodeoxycholate, in an animal model of familial adenomatous polyposis. Mice susceptible to intestinal tumors as a result of a germline mutation in Apc (Min/ϩ mice) were given a 10 week dietary treatment with 0.5% chenodeoxycholate. Following this, the mice were examined to determine tumor number, enterocyte proliferation, apoptosis and β-catenin expression. Intestinal tissue prostaglandin E 2 (PGE 2 ) levels were also assessed. Administration of chenodeoxycholate in the diet increased duodenal tumor number in Min/ϩ mice. Promotion of duodenal tumor formation was accompanied by increased β-catenin expression in duodenal cells, as well as increased PGE 2 in duodenal tissue. These data suggest that unconjugated bile acids contribute to periampullary tumor formation in the setting of an Apc mutation.
Introduction
A substantial body of evidence suggests that bile acids play a role in the development of intestinal tumors. In humans, epidemiological studies indicate that colon cancer is increased following cholecystectomy (1, 2) and by consumption of a high fat, low fiber diet (3, 4) , conditions that are associated with bile acid excess. Secondary bile acids are also increased in patients with colorectal adenomas (5) . In rodent models, dietary administration of bile acids increases intestinal neoplasia (6) (7) (8) (9) (10) (11) . Bile acids induce AP-1 mediated gene transcription in colon cancer cell lines (8) , and are potent activators of protein kinase C isoenzymes (10, 12, 13) .
Colorectal carcinoma is a multistage process characterized by the successive acquisition of mutations in the genes governing cellular growth and differentiation. The Apc gene is a key regulator of epithelial growth and mutation of Apc is one of the earliest events in the adenoma-carcinoma sequence (14) . Apc is mutated in Ͼ85% of sporadic human colorectal cancers (15) . Humans with a germline mutation of Apc, a condition known as Familial Adenomatous Polyposis (FAP), develop multiple tumors in the colorectum and the duodenum. Through the characterization of Apc protein as a modulator of intestinal cell growth, FAP is now recognized as a model relevant to sporadic as well as familial colorectal cancer.
Epigenetic factors, such as diet and exposure to chemical carcinogens, modulate the process of intestinal carcinogenesis. In patients with FAP, duodenal tumors are clustered around the ampulla of Vater, suggesting that biliary secretions play a role in tumor formation. The C57BL/6J-Min/ϩ (Min/ϩ) mouse is an animal model of FAP. Min/ϩ mice carry a germline mutation of Apc that produces a truncated Apc protein (16) . These animals develop multiple tumors, located primarily in the small intestine, and exhibit altered growth kinetics in the pre-neoplastic intestinal epithelium (17) . The stable genetic background of the Min/ϩ mouse provides an excellent model for studying epigenetic modulation of intestinal carcinogenesis.
To study the role of bile acids in Apc-associated carcinogenesis, we determined the effect of dietary administration of an unconjugated bile acid, chenodeoxycholate, upon tumor formation in the Min/ϩ mouse. We also measured the effect of chenodeoxycholate upon duodenal cell proliferation, apoptosis and β-catenin expression. We found that dietary administration of chenodeoxycholate increased duodenal tumor formation in Min/ϩ mice. This effect was associated with elevated enterocyte β-catenin expression and increased levels of prostaglandins in duodenal tissue. These results suggest that unconjugated bile acids contribute to duodenal tumor formation in the setting of Apc mutation.
Materials and methods

Treatment of Min/ϩ mice with bile acids
Female Min/ϩ mice were obtained at 5 weeks of age from Jackson Laboratories (Bar Harbor, ME) and started on experimental feeds on arrival. Pelleted feeds were prepared by Research Diets (New Brunswick, NJ). Chenodeoxycholic acid (98% pure) was obtained from Aldrich Chemical (St Louis, MO). Test diets consisted of AIN-76A supplemented with 0.5% chenodeoxycholic acid (w/w). Control Min/ϩ mice and their wild-type littermates (ϩ/ϩ) were fed AIN-76A diet without bile acid supplementation. Animals and their food were weighed twice weekly and checked daily for signs of weight loss or lethargy that may indicate intestinal obstruction or anemia. During the course of the experiment there was no difference in body weight or food consumption among the various study groups, and the animals remained active, suggesting that there was no toxicity in the treatment group. At 110 days of age, all mice were killed by CO 2 inhalation, and their intestinal tracts were removed from esophagus to distal rectum, opened, flushed with saline, and the entire length was examined under 3ϫ magnification to obtain tumor counts. The tumors were counted by an individual blinded to the animal's genetic status and treatment. Multiple samples of normal-appearing full-thickness small intestine were harvested and fixed in 10% formalin for histologic examination. Samples used for the analyses were taken from the duodenum, the mid small intestine and the middle portion of the colon.
Tissue histology
For each animal, 10-15 sections of small intestinal mucosa were examined. Specimens of small intestine of~5 mm in length were formalin fixed, embedded in paraffin and sectioned at 3 µm. Sections were stained with at Pennsylvania State University on February 23, 2013 http://carcin.oxfordjournals.org/ Downloaded from hematoxylin and eosin for evaluation of mucosal histology. For studies of nuclear density, Fuelgen staining was performed. To prepare sections for immunohistochemistry, sections of small intestine were deparaffinized and dehydrated by processing the slides with Hemo-De (Fisher Scientific, Pittsburgh, PA) and an alcohol series, followed by washing in phosphatebuffered saline (PBS; pH 7).
Measurement of prostaglandin E 2 (PGE 2 ) PGE 2 measurements were performed as described previously (18) . Intact small intestine, rather than intestinal mucosa only, was used for this study because a relatively large volume of material was required for analysis. Samples were homogenized, transferred to microcentrifuge tubes and centrifuged at 4°C for 10 min at 10 000 g. The supernatant was decanted, and a 10 µl aliquot of supernatant was used to determine protein concentration with a Bicinchoninic Acid Protein Assay Kit (Sigma, St Louis, MO). Determination of PGE 2 levels by EIA was accomplished using a Prostaglandin E 2 -Monoclonal Enzyme Immunoassay Kit (Cayman Chemical, Ann Arbor, MI). Plates were read at 410 nm with a UV max Kinetic Plate Reader (Molecular Devices, San Jose, CA). Data were computerized with DeltaSoft 3 and statistics performed with InStat 2.00 software.
Measurement of enterocyte proliferation
Small bowel sections were deparaffinized and rehydrated and endogenous peroxidase activity was blocked by incubating the slides with 0.45% methanol/ H 2 O 2 . Antigen retrieval was achieved by microwaving. Proliferating cell nuclear antigen (PCNA) antibody (Dako, Carpinteria, CA) was applied and incubated for 1 h at room temperature. Indirect detection was performed by incubating with secondary biotinylated horse anti-mouse IgG followed by Vector Elite ABC for 30 min at room temperature. Incubation for 5 min in DAB was utilized for color development. The specimens were counterstained with methyl green. For each specimen, eight crypt-villus units were chosen randomly from serial sections of small bowel mucosa by an individual blinded to the animal's genetic status. The percent staining of enterocytes in these crypt-villus units was measured using the Cell Analysis System 200 and CAS 200 Quantitative Nuclear Analysis Software (CAS 200).
In situ detection of apoptosis
To determine the percentage and distribution of epithelial cells undergoing cell death, we employed an in situ direct immunoperoxidase technique for determining cell death using the ApopTag Kit (Oncor, Gaithersburg, MD) as previously described (18) . Mouse lymphoid tissue with a known 2-3% rate of apoptosis was used as a positive control. For each specimen, eight cryptvillus units were chosen randomly from serial sections of small intestinal mucosa by an individual blinded to the animal's treatment group and genetic status. The percent staining of enterocytes in these crypt-villus units was measured using the CAS 200. To confirm that uniform sampling was achieved, nuclear density was measured and confirmed to be equal throughout the three study groups.
Determination of β-catenin expression Slides were deparaffinized in xylene for 10 min followed by alcohol rehydration. After quenching endogenous peroxidases with 0.45% H 2 O 2 in methanol, the slides were rinsed in PBS and an antigen retrieval step was carried out in a 700 W microwave oven for 10 min in pH 6.0 citrate buffer. The slides were then incubated with a monoclonal antibody to β-catenin (Transduction Laboratories, Lexington, KY) at 25°C for 1 h. Horse antimouse IgG secondary antibody was added for 30 min at 25°C followed by the Vector Elite ABC kit according to the manufacturer's instructions. The slides were stained with diaminobenzidine for 5 min and counterstained with methyl green. Analysis was carried out using the CAS 200.
Results
Chenodeoxycholic acid increases duodenal tumor formation in Min/ϩ mice
To determine the effect of increased intestinal bile acids on Apc-mediated carcinogenesis, we administered 0.5% chenodeoxycholate to Min/ϩ mice as a dietary additive. After 10 weeks of bile acid supplemented diet, the animals were killed and their intestines examined to obtain macroscopic tumor counts. For the small and large intestines, there were no significant differences in tumor number between treatment and control animals (Table I ). In the duodenum, however, chenodeoxycholic acid induced a 9-fold increase in tumor number compared with that seen in untreated Min/ϩ mice (Table I) . Previous studies show that pre-neoplastic intestinal mucosa in the Min/ϩ mouse exhibits reduced levels of apoptosis, as well as a compensatory decrease in enterocyte proliferation (17) . The net result of these changes is a decrease in enterocyte migration rate. We therefore measured proliferation and apoptosis in our study animals using immunohistochemical techniques. Enterocyte proliferation was assessed by staining actively dividing cells with an antibody to PCNA. Apoptosis was measured by terminal transferase-mediated deoxyuridine triphosphate-biotin nick end labeling (TUNEL), an in situ measure of the genomic DNA degradation induced by programmed cell death. When Min/ϩ mice were compared with their wild-type littermates, duodenal enterocyte proliferation and apoptosis were significantly reduced, consistent with that found in other studies of the small intestine of Min/ϩ mice (15) (16) (17) (18) (19) (Figures 1 and 2 ). There was no change in the general location of proliferating cells or of cells undergoing apoptosis, i.e. the proliferating cells were found in the upper third of the crypts, with apoptotic cells generally confined to the tips of the villi. Although there was a trend toward a further decrease in apoptosis and proliferation in the duodenum of bile acid-treated animals, this was not significantly different from that already produced by the Min mutation (Figures 1  and 2 ).
Chenodeoxycholic acid increases intracellular β-catenin expression in Min/ϩ duodenal mucosa
The Apc protein regulates intracellular levels of β-catenin, a component of the actin cytoskeleton that also tracks to the nucleus where it may facilitate transcription of genes governing cell growth. We therefore assessed cytoplasmic β-catenin levels in Min/ϩ mice treated with dietary bile acids. Tissue sections from the duodenum of study mice were stained with a polyclonal antibody to β-catenin. In agreement with previous studies, we found that the histologically normal mucosa of Min/ϩ animals exhibited increased staining with anti-β-catenin antibody when compared with ϩ/ϩ controls (Figure 3 
Chenodeoxycholic acid increases duodenal tissue PGE 2 levels
Cyclooxygenases catalyze the synthesis of prostaglandins from arachidonic acid. Overexpression of cyclooxygenase-2 (Cox-2) is observed in both human and murine colon cancers (18, 20) and eliminating the function of Cox-2 dramatically decreases tumor number in Apc-deficient mice (21) . In previous studies, we found increased tissue PGE 2 in the small intestines of Min/ϩ mice. We therefore studied the effect of chenodeoxycholate administration on levels of PGE 2 in duodenal tissue. As expected, PGE 2 levels were increased 6-fold in the duodenum of Min/ϩ animals when compared with wild-type controls (Figure 4) . Dietary administration of chenodeoxy- Fig. 3 . Chenodeoxycholate increases β-catenin expression in Min/ϩ duodenum. Specimens of duodenum from animals at 110 days of age were formalin fixed, embedded in paraffin and sectioned at 5 µm. Where indicated, animals were treated with chenodeoxycholate (0.5% by weight) as described in Materials and methods. Sections were stained with antibody to β-catenin. The percent staining of enterocytes in these crypt-villus units was measured by an observer blinded to the animal's genetic or treatment status using the CAS 200. Values represented are Ϯ SEM where n ϭ 20 animals (ϩ/ϩ and Min/ϩ); n ϭ 26 animals (Min/ϩ CD). *P Ͻ 0.0001 compared with Min/ϩ; **P Ͻ 0.0001 compared with Min/ϩ. cholate further increased tissue PGE 2 to nearly seven times that of wild-type animals and 54% greater than that of Min/ϩ mice (Figure 4 ). These data suggest that chenodeoxycholate increases arachidonic acid metabolism in the duodenum, providing a possible mechanism of tumor promotion by this compound.
Discussion
Clustering of tumor surrounding the ampulla of Vater is a characteristic of patients with FAP, suggesting that bile plays a role in the pathogenesis of Apc-related duodenal tumors. Bile contains many different substances, including bile acids, cholesterol and pigments such as bilirubin. In vitro studies show that bile from both normal individuals and patients with FAP can react with intracellular DNA to form covalent DNA adducts (22) . It is unclear whether bile-induced DNA adduct formation occurs in vivo, or whether the component of bile causing this effect is a bile acid (23, 24) . Compared with normal controls, bile from patients with FAP has a higher concentration of bile acids and a greater proportion of chenodeoxycholic acid (25) . In this study, we found that dietary at Pennsylvania State University on February 23, 2013 http://carcin.oxfordjournals.org/ Downloaded from administration of chenodeoxycholic acid increased tumors in the duodenum of animals with a germline Apc mutation. This study does not allow us to identify whether this results from a genotoxic interaction, or whether the bile acid acts primarily as a tumor promoter. The bile acids that are secreted into the duodenum are primarily conjugated with glycine or taurine. The activity of intestinal bacteria in the lower gastrointestinal tract converts these bile acids to their unconjugated forms. Most studies suggest that it is the unconjugated form of a bile acid that promotes intestinal tumor formation. Our model is therefore different from the usual in vivo state, and may be more relevant to carcinogenesis in the lower gastrointestinal tract.
The exact mechanism of bile acid-mediated tumor promotion is unknown. In animal studies, direct application of unconjugated bile acids to the intestinal epithelium results in epithelial damage, followed by increased enterocyte proliferation (26) (27) (28) (29) . Bile acids can activate protein kinase C (12,13), as well as induce AP-1-mediated gene transcription in cultured colon cancer cells (30) . Recent studies show that bile acids upregulate Cox-2 activity in vitro (31) , providing yet another link between arachidonic acid synthesis and tumor promotion. The products of Cox-2 activity, e.g. prostaglandins such as PGE 2 , can inhibit enterocyte apoptosis, decrease tissue immune surveillance and increase tumor invasiveness (32) (33) (34) . We found that the duodenal tissue of Min/ϩ mice contained elevated PGE 2 , and that this arachidonic acid metabolite was further increased by chenodeoxycholate to seven times that of normal animals. Our results are therefore consistent with the theory that a bile acid-induced activation of prostaglandin synthesis enhances tumor formation. In light of this, it is interesting that humans with FAP that are treated with inhibitors of prostaglandin synthesis, such as sulindac, show decreased tumor formation in the large bowel but not the duodenum (35, 36) . One explanation for this may be that the extraordinarily high prostaglandin levels induced by bile cannot be overcome by the non-selective inhibitors of cyclooxygenase presently used to treat tumors in FAP patients.
In order for normal mucosal architecture to be maintained in the intestine, the opposing processes of enterocyte proliferation and apoptosis must be balanced. In previous studies of small intestinal mucosa from Min/ϩ mice, we found that both apoptosis and proliferation were decreased as a result of the Min Apc mutation (17) . In this study, we extend this observation to the duodenal mucosa. Although there was a slight further decrease in apoptosis and proliferation in chenodeoxycholate treated animals, this was not statistically significant. Decreased duodenal cell turnover, therefore, may not be a cause of the tumor-promoting effect of this bile acid.
Apc protein normally associates with GSK-3β, a serinethreonine glycogen synthase kinase (37) . This complex binds to and facilitates the degradation of β-catenin, an intracellular protein associated with the actin cytoskeleton (38) . The role of β-catenin in colorectal carcinogenesis is unclear. β-catenin is a component of the adherens junction of intestinal epithelial cells, and may therefore be a modulator of cell-cell adhesion or contact-associated growth regulation. β-catenin also binds to the DNA binding proteins, Tcf and Lef. In association with β-catenin, Tcf and Lef alter expression of genes that may govern cell proliferation and apoptosis (37, 38) .
In previous studies, we found that pre-malignant cells in the small intestine of Min/ϩ mice demonstrate increased cytoplasmic β-catenin expression (17) . The present study suggests that increased β-catenin expression is also seen in the duodenum of Apc-mutant mice. Furthermore, administration of chenodeoxycholate as a tumor promoter resulted in an additional increase in β-catenin expression. Although the exact role of β-catenin in intestinal tumorigenesis is unknown, these data show that mucosal β-catenin expression correlates with tumor development.
Dietary administration of chenodeoxycholate significantly increased duodenal tumors in Min/ϩ mice, but had no significant effect upon overall tumor number in the small or large intestines of treated animals. This result may be due to an increased sensitivity of the duodenum of Min/ϩ mice to bile acid-induced tumors. A more likely interpretation is that this distribution of tumors resulted from a dosing effect, as dietary administration of the unconjugated bile acid produces a higher concentration of bile acid in the proximal gastrointestinal tract.
In summary, the data presented here indicate that locally acting unconjugated bile acids increase tumor formation in the setting of Apc mutation. Furthermore, this effect is associated with increased PGE 2 production, suggesting that effective inhibition of prostaglandin synthesis in the duodenum may inhibit bile acid-associated tumor promotion.
